Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.87 USD | -3.25% | -3.25% | -43.71% |
05-06 | SAB Biotherapeutics, Inc. Appoints Jay Skyler, Md, to the Board of Directors | CI |
04-16 | SAB Biotherapeutics, Inc. Provides SAB-142 Trial Update | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.71% | 35.7M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.
- HC Wainwright Trims SAB Biotherapeutics' Price Target to $1 From $2, Keeps Buy Rating